Other languages Allurion Technologies Inc.

Equities

ALUR

US02008G1022

Delayed Nyse Other stock markets 12:56:27 21/05/2024 am IST			5-day change	1st Jan Change
1.64 ^USD	-7.34%		-15.46%	-56.15%

14/05	Earnings Flash (ALUR) ALLURION TECHNOLOGIES Reports Q1 Revenue $9.4M, vs. Street Est of $9M	MT
14/05	Allurion Technologies Inc. Reiterates Revenue Guidance for the Year 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Allurion Technologies Inc. Reiterates Revenue Guidance for the Year 2024	14/05
Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the First Quarter 2024	30/04
Sector Update: Health Care Stocks Slump Late Afternoon	05/04
Sector Update: Health Care Stocks Mixed in Afternoon Trading	04/04
Sector Update: Health Care	04/04
Top Midday Gainers	04/04
Allurion Technologies' Shares, Trading Volume Jump After US Launch of Weight-Loss System	04/04
Allurion Technologies, Inc. Expands Virtual Care Suite to the United States	04/04
Allurion Technologies Inc. Reiterates Earnings Guidance for the Full Year 2024	21/03
Allurion Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Allurion Technologies Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
Allurion Technologies Inc. Appoints Milena Alberti-Perez as Board of Directors as Audit Committee Chair	12/03
Allurion Technologies Inc. Appoints Brendan Gibbons as Its New Chief Legal Officer and Corporate Secretary	29/01
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss	23/01
Allurion Technologies, Inc.'s Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships	17/01
Allurion Technologies Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Full Year of 2023 and Full Year of 2024	08/01
Allurion Technologies Inc. Announces New Research Highlights the Positive Impact of GLP-1s and Other Anti-Obesity Medications on the Allurion Program	05/01
Allurion Technologies, Inc. Announces an Expanded Commercial Agreement with Weight Doctors	02/01
Allurion Technologies Inc. Announces Resignation of Chief Commercial Officer, Benoit Chardon, Effective December 31, 2023	16/12
Allurion Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Allurion Technologies Inc.

Equities

ALUR

US02008G1022

Other languages

Filters